Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Olga Simó"'
Autor:
Antelm Pujol, Pilar Sanchis, María I. Tamayo, Joana Nicolau, Félix Grases, Ana Espino, Ana Estremera, Elena Rigo, Guillermo J. Amengual, Manuel Rodríguez, José L. Ribes, Isabel Gomila, Olga Simó-Servat, Lluís Masmiquel
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Type 2 diabetes mellitus has a worldwide prevalence of 10.5% in the adult population (20–79 years), and by 2045, the prevalence is expected to keep rising to one in eight adults living with diabetes. Mild cognitive impairment has a global prevalenc
Externí odkaz:
https://doaj.org/article/2fc095f181d84301ad43b0ee82bacdd9
Autor:
Rubén G. Barriada, Olga Simó-Servat, Alejandra Planas, Cristina Hernández, Rafael Simó, David Masip
Publikováno v:
Applied Sciences, Vol 12, Iss 3, p 1401 (2022)
Cardiovascular diseases (CVD) are one of the leading causes of death in the developed countries. Previous studies suggest that retina blood vessels provide relevant information on cardiovascular risk. Retina fundus imaging (RFI) is a cheap medical im
Externí odkaz:
https://doaj.org/article/2431d4ebcfb046a8b82bf35e0db4cd09
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1320 (2021)
The concept of diabetic retinopathy as a microvascular disease has evolved and is now considered a more complex diabetic complication in which neurovascular unit impairment plays an essential role and, therefore, can be considered as a main therapeut
Externí odkaz:
https://doaj.org/article/c3f0ae925ace4c5fba2f6e8bb268120c
Autor:
Rafael Simó, Patricia Bogdanov, Hugo Ramos, Jordi Huerta, Olga Simó-Servat, Cristina Hernández
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 926 (2021)
Background: An unexpected increase in the rate of severe diabetic retinopathy was observed in the Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN)-6 clinical trial. Although this effect was attributed to a rapid decrease in blood glucose levels
Externí odkaz:
https://doaj.org/article/e4badc6aafd8446fbcf8d8f8d6481acb
Autor:
Laura Gutierrez, David Garcia-Dorado, Joan Montaner, Rafael Simó, Jordi Bañeras, Cristina Hernández, José Rodríguez-Palomares, Filipa Valente, Teresa González-Alujas, Ignacio Ferreira, Santiago Aguadé-Bruix, Daniel Seron, Joan Genescà, Anna Boixadera, José García-Arumí, Alejandra Planas, Olga Simó-Servat
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 7, Iss 1 (2019)
Objective Detection of subclinical cardiovascular disease (CVD) has significant impact on the management of type 2 diabetes. We examined whether the assessment of diabetic retinopathy (DR) is useful for identifying patients at a higher risk of having
Externí odkaz:
https://doaj.org/article/b7be29c548f94829b64b621afcf1a657
Publikováno v:
Neural Regeneration Research, Vol 12, Iss 10, Pp 1620-1622 (2017)
Externí odkaz:
https://doaj.org/article/547123a4a87d4977beaefad1324a32ec
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Diabetic retinopathy (DR) is the main cause of working-age adult-onset blindness. The currently available treatments for DR are applicable only at advanced stages of the disease and are associated with significant adverse effects. In early stages of
Externí odkaz:
https://doaj.org/article/97166dd2d29444d0bf38c8444351ca91
Publikováno v:
Mediators of Inflammation, Vol 2012 (2012)
Diabetic retinopathy (DR) is the major cause of acquired blindness in working-age adults. Current treatments for DR (laser photocoagulation, intravitreal corticosteroids, intravitreal antivascular endothelial growth factor (VEGF) agents, and vitreo-r
Externí odkaz:
https://doaj.org/article/48b78f563308453d9395d0ad373f4c11
Autor:
David Rudilla, Elena García, Ángel M. Ortiz-Zúñiga, María Clemente León, Lía Nattero-Chávez, Andrés Mingorance, Ana Prado, Laura Galiana, Amparo Oliver, Olga Simó-Servat
Publikováno v:
Endocrinología, Diabetes y Nutrición. 70:4-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181da3d05ffdbb51cbe9e8d13495be35
https://doi.org/10.1016/j.endinu.2022.07.008
https://doi.org/10.1016/j.endinu.2022.07.008
Publikováno v:
In FMC. Formación médica continuada en atención primaria February 2017 24(2):64-69